APO Research

APO RESEARCH · REPORT

Custom Synthetic Genes

Selected research

Market Analysis & Forecast

Global Custom Synthetic Genes Market Analysis and Forecast 2026-2032

Market perspective

The global Custom Synthetic Genes market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Custom Synthetic Genes is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Custom Synthetic Genes is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Custom Synthetic Genes is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Custom Synthetic Genes is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Custom Synthetic Genes include Azenta Life Sciences, BBI, Bio Basic, DNA 2.0 (ATUM), Eurofins Genomics, Genescript, IDT, OriGene and SBS Genetech, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Custom Synthetic Genes, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Custom Synthetic Genes, also provides the revenue of main regions and countries. Of the upcoming market potential for Custom Synthetic Genes, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Custom Synthetic Genes revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Custom Synthetic Genes market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Custom Synthetic Genes revenue, projected growth trends, production technology, application and end-user industry.

Custom Synthetic Genes Segment by Company

Azenta Life Sciences

BBI

Bio Basic

DNA 2.0 (ATUM)

Eurofins Genomics

Genescript

IDT

OriGene

SBS Genetech

Thermo Scientific

Twist Bioscience

Custom Synthetic Genes Segment by Type

Above 5000 bp

3001- 5000 bp

1001 - 3000 bp

Below 1000 bp

Custom Synthetic Genes Segment by Application

Commercial

Academic Research

Custom Synthetic Genes Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Custom Synthetic Genes market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Custom Synthetic Genes and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Custom Synthetic Genes.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Custom Synthetic Genes in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Custom Synthetic Genes company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Custom Synthetic Genes revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Custom Synthetic Genes Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Above 5000 bp Major Player Table 3. 3001- 5000 bp Major Player Table 4. 1001 - 3000 bp Major Player Table 5. Below 1000 bp Major Player Table 6. Global Custom Synthetic Genes Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Commercial Major Player Table 8. Academic Research Major Player Table 9. Custom Synthetic Genes Industry Trends Table 10. Custom Synthetic Genes Industry Drivers Table 11. Custom Synthetic Genes Industry Opportunities and Challenges Table 12. Custom Synthetic Genes Industry Restraints Table 13. Global Custom Synthetic Genes Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Custom Synthetic Genes Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Custom Synthetic Genes Market Share by Region (2021-2026) Table 16. Global Custom Synthetic Genes Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Custom Synthetic Genes Market Share by Region (2027-2032) Table 18. Global Custom Synthetic Genes Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Custom Synthetic Genes Revenue Market Share by Players (2021-2026) Table 20. Global Custom Synthetic Genes Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Custom Synthetic Genes Key Players Headquarters & Area Served Table 22. Global Custom Synthetic Genes Players, Product Type & Application Table 23. Global Custom Synthetic Genes Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Custom Synthetic Genes by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Custom Synthetic Genes Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Custom Synthetic Genes Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Custom Synthetic Genes Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Custom Synthetic Genes Revenue Market Share by Type (2021-2026) Table 30. Global Custom Synthetic Genes Revenue Market Share by Type (2027-2032) Table 31. Global Custom Synthetic Genes Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Custom Synthetic Genes Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Custom Synthetic Genes Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Custom Synthetic Genes Revenue Market Share by Application (2021-2026) Table 35. Global Custom Synthetic Genes Revenue Market Share by Application (2027-2032) Table 36. Azenta Life Sciences Company Information Table 37. Azenta Life Sciences Business Overview Table 38. Azenta Life Sciences Custom Synthetic Genes Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Azenta Life Sciences Custom Synthetic Genes Product Portfolio Table 40. Azenta Life Sciences Recent Development Table 41. BBI Company Information Table 42. BBI Business Overview Table 43. BBI Custom Synthetic Genes Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. BBI Custom Synthetic Genes Product Portfolio Table 45. BBI Recent Development Table 46. Bio Basic Company Information Table 47. Bio Basic Business Overview Table 48. Bio Basic Custom Synthetic Genes Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Bio Basic Custom Synthetic Genes Product Portfolio Table 50. Bio Basic Recent Development Table 51. DNA 2.0 (ATUM) Company Information Table 52. DNA 2.0 (ATUM) Business Overview Table 53. DNA 2.0 (ATUM) Custom Synthetic Genes Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. DNA 2.0 (ATUM) Custom Synthetic Genes Product Portfolio Table 55. DNA 2.0 (ATUM) Recent Development Table 56. Eurofins Genomics Company Information Table 57. Eurofins Genomics Business Overview Table 58. Eurofins Genomics Custom Synthetic Genes Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Eurofins Genomics Custom Synthetic Genes Product Portfolio Table 60. Eurofins Genomics Recent Development Table 61. Genescript Company Information Table 62. Genescript Business Overview Table 63. Genescript Custom Synthetic Genes Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Genescript Custom Synthetic Genes Product Portfolio Table 65. Genescript Recent Development Table 66. IDT Company Information Table 67. IDT Business Overview Table 68. IDT Custom Synthetic Genes Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. IDT Custom Synthetic Genes Product Portfolio Table 70. IDT Recent Development Table 71. OriGene Company Information Table 72. OriGene Business Overview Table 73. OriGene Custom Synthetic Genes Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. OriGene Custom Synthetic Genes Product Portfolio Table 75. OriGene Recent Development Table 76. SBS Genetech Company Information Table 77. SBS Genetech Business Overview Table 78. SBS Genetech Custom Synthetic Genes Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. SBS Genetech Custom Synthetic Genes Product Portfolio Table 80. SBS Genetech Recent Development Table 81. Thermo Scientific Company Information Table 82. Thermo Scientific Business Overview Table 83. Thermo Scientific Custom Synthetic Genes Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Thermo Scientific Custom Synthetic Genes Product Portfolio Table 85. Thermo Scientific Recent Development Table 86. Twist Bioscience Company Information Table 87. Twist Bioscience Business Overview Table 88. Twist Bioscience Custom Synthetic Genes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Twist Bioscience Custom Synthetic Genes Product Portfolio Table 90. Twist Bioscience Recent Development Table 91. North America Custom Synthetic Genes Revenue by Type (2021-2026) & (US$ Million) Table 92. North America Custom Synthetic Genes Revenue by Type (2027-2032) & (US$ Million) Table 93. North America Custom Synthetic Genes Revenue by Application (2021-2026) & (US$ Million) Table 94. North America Custom Synthetic Genes Revenue by Application (2027-2032) & (US$ Million) Table 95. North America Custom Synthetic Genes Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 96. North America Custom Synthetic Genes Revenue by Country (2021-2026) & (US$ Million) Table 97. North America Custom Synthetic Genes Revenue by Country (US$ Million) & (2027-2032) Table 98. Europe Custom Synthetic Genes Revenue by Type (2021-2026) & (US$ Million) Table 99. Europe Custom Synthetic Genes Revenue by Type (2027-2032) & (US$ Million) Table 100. Europe Custom Synthetic Genes Revenue by Application (2021-2026) & (US$ Million) Table 101. Europe Custom Synthetic Genes Revenue by Application (2027-2032) & (US$ Million) Table 102. Europe Custom Synthetic Genes Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 103. Europe Custom Synthetic Genes Revenue by Country (2021-2026) & (US$ Million) Table 104. Europe Custom Synthetic Genes Revenue by Country (US$ Million) & (2027-2032) Table 105. China Custom Synthetic Genes Revenue by Type (2021-2026) & (US$ Million) Table 106. China Custom Synthetic Genes Revenue by Type (2027-2032) & (US$ Million) Table 107. China Custom Synthetic Genes Revenue by Application (2021-2026) & (US$ Million) Table 108. China Custom Synthetic Genes Revenue by Application (2027-2032) & (US$ Million) Table 109. Asia Custom Synthetic Genes Revenue by Type (2021-2026) & (US$ Million) Table 110. Asia Custom Synthetic Genes Revenue by Type (2027-2032) & (US$ Million) Table 111. Asia Custom Synthetic Genes Revenue by Application (2021-2026) & (US$ Million) Table 112. Asia Custom Synthetic Genes Revenue by Application (2027-2032) & (US$ Million) Table 113. Asia Custom Synthetic Genes Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 114. Asia Custom Synthetic Genes Revenue by Region (US$ Million) & (2021-2026) Table 115. Asia Custom Synthetic Genes Revenue by Region (US$ Million) & (2027-2032) Table 116. SAMEA Custom Synthetic Genes Revenue by Type (2021-2026) & (US$ Million) Table 117. SAMEA Custom Synthetic Genes Revenue by Type (2027-2032) & (US$ Million) Table 118. SAMEA Custom Synthetic Genes Revenue by Application (2021-2026) & (US$ Million) Table 119. SAMEA Custom Synthetic Genes Revenue by Application (2027-2032) & (US$ Million) Table 120. SAMEA Custom Synthetic Genes Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 121. SAMEA Custom Synthetic Genes Revenue by Country (2021-2026) & (US$ Million) Table 122. SAMEA Custom Synthetic Genes Revenue by Country (US$ Million) & (2027-2032) Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources Table 126. Primary Sources List of Figures Figure 1. Custom Synthetic Genes Image Figure 2. Global Custom Synthetic Genes Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Custom Synthetic Genes Market Size Share 2021 VS 2025 VS 2032 Figure 4. Above 5000 bp Image Figure 5. 3001- 5000 bp Image Figure 6. 1001 - 3000 bp Image Figure 7. Below 1000 bp Image Figure 8. Global Custom Synthetic Genes Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Custom Synthetic Genes Market Size Share 2021 VS 2025 VS 2032 Figure 10. Commercial Image Figure 11. Academic Research Image Figure 12. Global Custom Synthetic Genes Market Size (US$ Million) & (2021-2032) Figure 13. Global Custom Synthetic Genes Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Custom Synthetic Genes Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Custom Synthetic Genes Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Custom Synthetic Genes Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Custom Synthetic Genes Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Custom Synthetic Genes Revenue Market Share by Type (2021-2032) Figure 20. Global Custom Synthetic Genes Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Custom Synthetic Genes Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Custom Synthetic Genes Revenue Market Share by Application (2021-2032) Figure 23. North America Custom Synthetic Genes Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Custom Synthetic Genes Revenue Share by Type (2021-2032) Figure 25. North America Custom Synthetic Genes Revenue Share by Application (2021-2032) Figure 26. North America Custom Synthetic Genes Revenue Share by Country (2021-2032) Figure 27. United States Custom Synthetic Genes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Custom Synthetic Genes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Custom Synthetic Genes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Custom Synthetic Genes Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Custom Synthetic Genes Revenue Share by Type (2021-2032) Figure 32. Europe Custom Synthetic Genes Revenue Share by Application (2021-2032) Figure 33. Europe Custom Synthetic Genes Revenue Share by Country (2021-2032) Figure 34. Germany Custom Synthetic Genes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Custom Synthetic Genes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Custom Synthetic Genes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Custom Synthetic Genes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Custom Synthetic Genes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Custom Synthetic Genes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Custom Synthetic Genes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Custom Synthetic Genes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Custom Synthetic Genes Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Custom Synthetic Genes Revenue Share by Type (2021-2032) Figure 44. China Custom Synthetic Genes Revenue Share by Application (2021-2032) Figure 45. Asia Custom Synthetic Genes Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Custom Synthetic Genes Revenue Share by Type (2021-2032) Figure 47. Asia Custom Synthetic Genes Revenue Share by Application (2021-2032) Figure 48. Asia Custom Synthetic Genes Revenue Share by Region (2021-2032) Figure 49. Japan Custom Synthetic Genes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Custom Synthetic Genes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Custom Synthetic Genes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Custom Synthetic Genes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Custom Synthetic Genes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Custom Synthetic Genes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Custom Synthetic Genes Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Custom Synthetic Genes Revenue Share by Type (2021-2032) Figure 57. SAMEA Custom Synthetic Genes Revenue Share by Application (2021-2032) Figure 58. SAMEA Custom Synthetic Genes Revenue Share by Country (2021-2032) Figure 59. Brazil Custom Synthetic Genes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Custom Synthetic Genes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Custom Synthetic Genes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Custom Synthetic Genes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Custom Synthetic Genes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Custom Synthetic Genes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Custom Synthetic Genes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Custom Synthetic Genes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Custom Synthetic Genes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Custom Synthetic Genes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Custom Synthetic Genes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Above 5000 bp
  • 3001- 5000 bp
  • 1001 - 3000 bp
  • Below 1000 bp
Applications
  • Commercial
  • Academic Research
Companies covered
  • Azenta Life Sciences
  • BBI
  • Bio Basic
  • DNA 2.0 (ATUM)
  • Eurofins Genomics
  • Genescript
  • IDT
  • OriGene
  • SBS Genetech
  • Thermo Scientific
  • Twist Bioscience

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Custom Synthetic Genes Market by Type
  3. 1.2.1 Global Custom Synthetic Genes Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Above 5000 bp
  5. 1.2.3 3001- 5000 bp
  6. 1.2.4 1001 - 3000 bp
  7. 1.2.5 Below 1000 bp
  8. 1.3 Custom Synthetic Genes Market by Application
  9. 1.3.1 Global Custom Synthetic Genes Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Commercial
  11. 1.3.3 Academic Research
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Custom Synthetic Genes Market Dynamics
  1. 2.1 Custom Synthetic Genes Industry Trends
  2. 2.2 Custom Synthetic Genes Industry Drivers
  3. 2.3 Custom Synthetic Genes Industry Opportunities and Challenges
  4. 2.4 Custom Synthetic Genes Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Custom Synthetic Genes Market Perspective (2021-2032)
  2. 3.2 Global Custom Synthetic Genes Growth Trends by Region
  3. 3.2.1 Global Custom Synthetic Genes Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Custom Synthetic Genes Market Size by Region (2021-2026)
  5. 3.2.3 Global Custom Synthetic Genes Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Custom Synthetic Genes Revenue by Players
  2. 4.1.1 Global Custom Synthetic Genes Revenue by Players (2021-2026)
  3. 4.1.2 Global Custom Synthetic Genes Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Custom Synthetic Genes Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Custom Synthetic Genes Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Custom Synthetic Genes Key Players Headquarters & Area Served
  7. 4.4 Global Custom Synthetic Genes Players, Product Type & Application
  8. 4.5 Global Custom Synthetic Genes Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Custom Synthetic Genes Market CR5 and HHI
  11. 4.6.3 2025 Custom Synthetic Genes Tier 1, Tier 2, and Tier 3
5 Custom Synthetic Genes Market Size by Type
  1. 5.1 Global Custom Synthetic Genes Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Custom Synthetic Genes Revenue by Type (2021-2032)
  3. 5.3 Global Custom Synthetic Genes Revenue Market Share by Type (2021-2032)
6 Custom Synthetic Genes Market Size by Application
  1. 6.1 Global Custom Synthetic Genes Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Custom Synthetic Genes Revenue by Application (2021-2032)
  3. 6.3 Global Custom Synthetic Genes Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Azenta Life Sciences
  2. 7.1.1 Azenta Life Sciences Company Information
  3. 7.1.2 Azenta Life Sciences Business Overview
  4. 7.1.3 Azenta Life Sciences Custom Synthetic Genes Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Azenta Life Sciences Custom Synthetic Genes Product Portfolio
  6. 7.1.5 Azenta Life Sciences Recent Developments
  7. 7.2 BBI
  8. 7.2.1 BBI Company Information
  9. 7.2.2 BBI Business Overview
  10. 7.2.3 BBI Custom Synthetic Genes Revenue and Gross Margin (2021-2026)
  11. 7.2.4 BBI Custom Synthetic Genes Product Portfolio
  12. 7.2.5 BBI Recent Developments
  13. 7.3 Bio Basic
  14. 7.3.1 Bio Basic Company Information
  15. 7.3.2 Bio Basic Business Overview
  16. 7.3.3 Bio Basic Custom Synthetic Genes Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Bio Basic Custom Synthetic Genes Product Portfolio
  18. 7.3.5 Bio Basic Recent Developments
  19. 7.4 DNA 2.0 (ATUM)
  20. 7.4.1 DNA 2.0 (ATUM) Company Information
  21. 7.4.2 DNA 2.0 (ATUM) Business Overview
  22. 7.4.3 DNA 2.0 (ATUM) Custom Synthetic Genes Revenue and Gross Margin (2021-2026)
  23. 7.4.4 DNA 2.0 (ATUM) Custom Synthetic Genes Product Portfolio
  24. 7.4.5 DNA 2.0 (ATUM) Recent Developments
  25. 7.5 Eurofins Genomics
  26. 7.5.1 Eurofins Genomics Company Information
  27. 7.5.2 Eurofins Genomics Business Overview
  28. 7.5.3 Eurofins Genomics Custom Synthetic Genes Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Eurofins Genomics Custom Synthetic Genes Product Portfolio
  30. 7.5.5 Eurofins Genomics Recent Developments
  31. 7.6 Genescript
  32. 7.6.1 Genescript Company Information
  33. 7.6.2 Genescript Business Overview
  34. 7.6.3 Genescript Custom Synthetic Genes Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Genescript Custom Synthetic Genes Product Portfolio
  36. 7.6.5 Genescript Recent Developments
  37. 7.7 IDT
  38. 7.7.1 IDT Company Information
  39. 7.7.2 IDT Business Overview
  40. 7.7.3 IDT Custom Synthetic Genes Revenue and Gross Margin (2021-2026)
  41. 7.7.4 IDT Custom Synthetic Genes Product Portfolio
  42. 7.7.5 IDT Recent Developments
  43. 7.8 OriGene
  44. 7.8.1 OriGene Company Information
  45. 7.8.2 OriGene Business Overview
  46. 7.8.3 OriGene Custom Synthetic Genes Revenue and Gross Margin (2021-2026)
  47. 7.8.4 OriGene Custom Synthetic Genes Product Portfolio
  48. 7.8.5 OriGene Recent Developments
  49. 7.9 SBS Genetech
  50. 7.9.1 SBS Genetech Company Information
  51. 7.9.2 SBS Genetech Business Overview
  52. 7.9.3 SBS Genetech Custom Synthetic Genes Revenue and Gross Margin (2021-2026)
  53. 7.9.4 SBS Genetech Custom Synthetic Genes Product Portfolio
  54. 7.9.5 SBS Genetech Recent Developments
  55. 7.10 Thermo Scientific
  56. 7.10.1 Thermo Scientific Company Information
  57. 7.10.2 Thermo Scientific Business Overview
  58. 7.10.3 Thermo Scientific Custom Synthetic Genes Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Thermo Scientific Custom Synthetic Genes Product Portfolio
  60. 7.10.5 Thermo Scientific Recent Developments
  61. 7.11 Twist Bioscience
  62. 7.11.1 Twist Bioscience Company Information
  63. 7.11.2 Twist Bioscience Business Overview
  64. 7.11.3 Twist Bioscience Custom Synthetic Genes Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Twist Bioscience Custom Synthetic Genes Product Portfolio
  66. 7.11.5 Twist Bioscience Recent Developments
8 North America
  1. 8.1 North America Custom Synthetic Genes Revenue (2021-2032)
  2. 8.2 North America Custom Synthetic Genes Revenue by Type (2021-2032)
  3. 8.2.1 North America Custom Synthetic Genes Revenue by Type (2021-2026)
  4. 8.2.2 North America Custom Synthetic Genes Revenue by Type (2027-2032)
  5. 8.3 North America Custom Synthetic Genes Revenue Share by Type (2021-2032)
  6. 8.4 North America Custom Synthetic Genes Revenue by Application (2021-2032)
  7. 8.4.1 North America Custom Synthetic Genes Revenue by Application (2021-2026)
  8. 8.4.2 North America Custom Synthetic Genes Revenue by Application (2027-2032)
  9. 8.5 North America Custom Synthetic Genes Revenue Share by Application (2021-2032)
  10. 8.6 North America Custom Synthetic Genes Revenue by Country
  11. 8.6.1 North America Custom Synthetic Genes Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Custom Synthetic Genes Revenue by Country (2021-2026)
  13. 8.6.3 North America Custom Synthetic Genes Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Custom Synthetic Genes Revenue (2021-2032)
  2. 9.2 Europe Custom Synthetic Genes Revenue by Type (2021-2032)
  3. 9.2.1 Europe Custom Synthetic Genes Revenue by Type (2021-2026)
  4. 9.2.2 Europe Custom Synthetic Genes Revenue by Type (2027-2032)
  5. 9.3 Europe Custom Synthetic Genes Revenue Share by Type (2021-2032)
  6. 9.4 Europe Custom Synthetic Genes Revenue by Application (2021-2032)
  7. 9.4.1 Europe Custom Synthetic Genes Revenue by Application (2021-2026)
  8. 9.4.2 Europe Custom Synthetic Genes Revenue by Application (2027-2032)
  9. 9.5 Europe Custom Synthetic Genes Revenue Share by Application (2021-2032)
  10. 9.6 Europe Custom Synthetic Genes Revenue by Country
  11. 9.6.1 Europe Custom Synthetic Genes Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Custom Synthetic Genes Revenue by Country (2021-2026)
  13. 9.6.3 Europe Custom Synthetic Genes Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Custom Synthetic Genes Revenue (2021-2032)
  2. 10.2 China Custom Synthetic Genes Revenue by Type (2021-2032)
  3. 10.2.1 China Custom Synthetic Genes Revenue by Type (2021-2026)
  4. 10.2.2 China Custom Synthetic Genes Revenue by Type (2027-2032)
  5. 10.3 China Custom Synthetic Genes Revenue Share by Type (2021-2032)
  6. 10.4 China Custom Synthetic Genes Revenue by Application (2021-2032)
  7. 10.4.1 China Custom Synthetic Genes Revenue by Application (2021-2026)
  8. 10.4.2 China Custom Synthetic Genes Revenue by Application (2027-2032)
  9. 10.5 China Custom Synthetic Genes Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Custom Synthetic Genes Revenue (2021-2032)
  2. 11.2 Asia Custom Synthetic Genes Revenue by Type (2021-2032)
  3. 11.2.1 Asia Custom Synthetic Genes Revenue by Type (2021-2026)
  4. 11.2.2 Asia Custom Synthetic Genes Revenue by Type (2027-2032)
  5. 11.3 Asia Custom Synthetic Genes Revenue Share by Type (2021-2032)
  6. 11.4 Asia Custom Synthetic Genes Revenue by Application (2021-2032)
  7. 11.4.1 Asia Custom Synthetic Genes Revenue by Application (2021-2026)
  8. 11.4.2 Asia Custom Synthetic Genes Revenue by Application (2027-2032)
  9. 11.5 Asia Custom Synthetic Genes Revenue Share by Application (2021-2032)
  10. 11.6 Asia Custom Synthetic Genes Revenue by Country
  11. 11.6.1 Asia Custom Synthetic Genes Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Custom Synthetic Genes Revenue by Country (2021-2026)
  13. 11.6.3 Asia Custom Synthetic Genes Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Custom Synthetic Genes Revenue (2021-2032)
  2. 12.2 SAMEA Custom Synthetic Genes Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Custom Synthetic Genes Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Custom Synthetic Genes Revenue by Type (2027-2032)
  5. 12.3 SAMEA Custom Synthetic Genes Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Custom Synthetic Genes Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Custom Synthetic Genes Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Custom Synthetic Genes Revenue by Application (2027-2032)
  9. 12.5 SAMEA Custom Synthetic Genes Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Custom Synthetic Genes Revenue by Country
  11. 12.6.1 SAMEA Custom Synthetic Genes Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Custom Synthetic Genes Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Custom Synthetic Genes Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research